Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Rasoul Mirzaei, Farzad Mahdavi, Fariba Badrzadeh, et al.
International Immunopharmacology (2020) Vol. 90, pp. 107204-107204
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases
Ashkan Rasouli‐Saravani, Kasra Jahankhani, Shadi Moradi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114620-114620
Open Access | Times Cited: 49
The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases
Rasoul Mirzaei, Farhad Zamani, Marzieh Hajibaba, et al.
Journal of Neuroimmunology (2021) Vol. 358, pp. 577640-577640
Closed Access | Times Cited: 86
Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19
Shama Ahmad, Shajer Manzoor, Sazia Siddiqui, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 384-398
Open Access | Times Cited: 76
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Sujay Paul, Luis Alberto Bravo-Vázquez, Paula Reyes‐Pérez, et al.
Virus Research (2021) Vol. 308, pp. 198631-198631
Open Access | Times Cited: 57
A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19)
Sajad Karampoor, Hamid Zahednasab, Mohammad Farahmand, et al.
International Immunopharmacology (2021) Vol. 97, pp. 107684-107684
Open Access | Times Cited: 50
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection
Riham Abdel‐Hamid Haroun, Waleed H. Osman, Rasha E. Amin, et al.
Pathology (2021) Vol. 54, Iss. 1, pp. 104-110
Open Access | Times Cited: 50
The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19)
Rasoul Mirzaei, Adeleh Attar, Saher Papizadeh, et al.
Archives of Virology (2021) Vol. 166, Iss. 7, pp. 1819-1840
Open Access | Times Cited: 47
Mechanisms contributing to adverse outcomes of COVID-19 in obesity
Manu Sudhakar, Sofi Beaula Winfred, Gowri Meiyazhagan, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 4, pp. 1155-1193
Open Access | Times Cited: 38
Role of genetic variants and host polymorphisms on COVID‐19: From viral entrance mechanisms to immunological reactions
Abolfazl Adli, Mandana Rahimi, Reza Khodaie, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1846-1865
Open Access | Times Cited: 37
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies
Mamta Panda, Elora Kalita, Satyendra Singh, et al.
Life Sciences (2022) Vol. 305, pp. 120761-120761
Open Access | Times Cited: 37
Coronavirus disease 2019 (COVID‐19) update: From metabolic reprogramming to immunometabolism
Mohammad Rudiansyah, Saade Abdalkareem Jasim, Zeinab Gol Mohammad pour, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 10, pp. 4611-4627
Open Access | Times Cited: 34
The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infection
Rasoul Mirzaei, Sajad Babakhani, Parisa Ajorloo, et al.
Molecular Medicine (2021) Vol. 27, Iss. 1
Open Access | Times Cited: 41
The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure
Ruth Pia Duecker, Elisabeth Adam, Sarah Wirtz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10351-10351
Open Access | Times Cited: 35
SARS-CoV-2 and COVID-19: A Narrative Review
Andrew D. Blann, Rebekka Heitmar
British Journal of Biomedical Science (2022) Vol. 79
Open Access | Times Cited: 26
MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review
Jivan Qasim Ahmed, Sazan Qadir Maulud, Manish Dhawan, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 7, pp. 788-799
Open Access | Times Cited: 25
Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS‐CoV‐2 and other respiratory viruses: A comprehensive review
Chiranjib Chakraborty, Manojit Bhattacharya, Sang‐Soo Lee
Reviews in Medical Virology (2024) Vol. 34, Iss. 2
Closed Access | Times Cited: 5
RNA Virus-Encoded miRNAs: Current Insights and Future Challenges
Asuka Nanbo, Wakako Furuyama, Zhen Lin
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 31
Role of Mirnas As Biomarkers of Covid-19: A Scoping Review of the Status and Future Directions for Research in This Field
Marília Berlofa Visacri, Aline de Souza Nicoletti, Eder de Carvalho Pincinato, et al.
Biomarkers in Medicine (2021) Vol. 15, Iss. 18, pp. 1785-1795
Open Access | Times Cited: 29
Nanoligomers Targeting Human miRNA for the Treatment of Severe COVID-19 Are Safe and Nontoxic in Mice
Colleen R. McCollum, Colleen M. Courtney, Nolan J. O’Connor, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 7, pp. 3087-3106
Closed Access | Times Cited: 22
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review
Beatrice Maranini, Giovanni Ciancìo, Manuela Ferracin, et al.
Life (2022) Vol. 12, Iss. 2, pp. 288-288
Open Access | Times Cited: 21
Angioregulatory role of miRNAs and exosomal miRNAs in glioblastoma pathogenesis
Behnaz Bouzari, Shabahang Mohammadi, Dmitry Olegovich Bokov, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112760-112760
Open Access | Times Cited: 20
miRNAs: The Key Regulator of COVID-19 Disease
Leyla Tahrani Hardin, Nan Xiao
International Journal of Cell Biology (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 20
Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients
Noha Mousaad Elemam, Hind Hasswan, Hayat Aljaibeji, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5263-5263
Open Access | Times Cited: 26
microRNA-146a-5p, Neurotropic Viral Infection and Prion Disease (PrD)
Aileen I. Pogue, Walter J. Lukiw
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9198-9198
Open Access | Times Cited: 25
Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects
Chia‐Yin Lee, Anh Thuc Nguyen, Ly Hien Doan, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 641-641
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top